Trials / Completed
CompletedNCT06236217
Prediction of Spinal Anesthesia-Induced Hypotension in Cesarian Section: Carotid Artery-Corrected Flow Time Versus Cardiometry
Prediction of Spinal Anesthesia-Induced Hypotension in Cesarian Section: Carotid Artery-Corrected Flow Time Versus Cardiometry: Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research aimed to evaluate and compare the role of carotid corrected flow time (FTc) and electrical cardiometry (EC) in the prediction and prevention of post-spinal hypotension in elective cesarian section.
Detailed description
Spinal anesthesia is the procedure of choice for elective cesarean section (CS) because it avoids the most common side effects related to general anesthesia, such as the risk of aspiration, airway problems and the negative effects of intravenous anesthetic drugs on the fetus. Accurate prediction of post-spinal hypotension could enhance clinical decision-making, optimize management, and facilitate early intervention. More than thirty predictors were used in the prediction of post-spinal hypotension including demographic data, hemodynamic variables, postural stress testing, peripheral perfusion indices, volume and fluid responsiveness indices, and genetic polymorphism. The baseline parameters obtained via the bioreactance-based system may serve as a predictor of post-spinal anesthesia hypotension in parturient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Carotid Ultrasound | The carotid artery corrected flow time (FTc) was used in patients to optimize the volume status before performing spinal anesthesia. |
| OTHER | Electrical cardiometry | Stroke volume variation (SVV) measured by electrical cardiometry (EC) was used to optimize the volume status before performing spinal anesthesia. |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2023-07-01
- Completion
- 2023-07-01
- First posted
- 2024-02-01
- Last updated
- 2024-02-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06236217. Inclusion in this directory is not an endorsement.